47.55MMarket Cap-0.34P/E (TTM)
2.180High1.670Low4.28MVolume1.810Open1.700Pre Close8.40MTurnover30.72%Turnover RatioLossP/E (Static)23.66MShares12.85052wk High-0.57P/B28.02MFloat Cap0.87052wk Low--Dividend TTM13.94MShs Float219.200Historical High--Div YieldTTM30.00%Amplitude0.870Historical Low1.961Avg Price1Lot Size
Outlook Therapeutics Stock Forum
1 min ago
Outlook Therapeutics Inc - First Positive Reimbursement Decision Worldwide for Lytenava™; First Launch Anticipated in H1 2025
this company very strong support company. until weight January you can get $5
loading...
No comment yet